chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The first menstrual cycle I had after the second dose was vastly different from what I have been experiencing. I have had intense levels of pain each cycle since the second shot due to endometriosis flares. I believe this was caused by the inflammation process associated with the vaccine. My cycles are also extremely light compared to what they had been previously. My quality of life has suffered.
testing positive with COVID-19; testing positive with COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 34-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 30Nov2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 33 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Birth Control" (unspecified if ongoing). Concomitant medication(s) received in 2 weeks included: AVIANE taken for contraception, start date: 01Jan2018; SPIRONOLACTONE, start date: 01Jan2020. Past drug history included: Aleve, reaction(s): "Known allergies: Aleve". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "testing positive with COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive; (May2022) Negative, notes: I tested negative on day 8, pcr and rapid; (16May2022) Positive, notes: testing positive again on day 12. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: The patient was treated with Paxlovid, treatment start date=11May2022, treatment stop date=16May2022. The patient was vaccinated, boosted and took Paxlovid upon symptom onset/testing positive with COVID-19. She tested negative on day 8, PCR and rapid, and felt much better. She began testing positive again on day 12. By day 13 symptoms returned - congestion, cough, stomach issues, etc. She was on day 14 and still feeling sick.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
This spontaneous report was received from a registered nurse via company representative referring to an unspecified number of patients of unknown age and gender. The patient's medical histories and concurrent conditions were not provided. On an unknown date, the patients were vaccinated with an unspecified dose of GARDASIL (lot number, dose, expiration date and route were not provided). Concomitant medications were not reported. It was reported that "a lot of patients faint after receiving GARDASIL". The outcome of syncope was unknown. The primary reporter did not provide the causality between GARDASIL and syncope. This is one of two reports from the same source. Additional information has been requested.
Getting sick; Skin sensitivity; Complained about skin sensitivity. Reported that clothes touching her skin and taking a shower was painful; This is a spontaneous report from a contactable consumer. A female patient of unknown age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, it was unknown whether the patient was diagnosed with COVID-19. It was unknown whether the patient received any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On an unknown date, after the second dose, the patient was getting sick and complained about skin sensitivity and reported that, clothes touching her skin and taking a shower was painful. Since the vaccination, it was unknown whether the patient had tested for COVID-19. The clinical outcome of the events getting sick, skin sensitivity and clothes touching her skin and taking a shower was painful was resolved on an unknown date.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Lightheaded; Sore arm; This is a spontaneous report from a non-contactable consumer reported that a patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at a single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced lightheaded for an hour or so after and really sore arm about 12 hours later; both on an unspecified date. The outcome of the events was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
I had 102 fever. I was vomiting. I had chills, body aches, feeling weak, and fatigue. These symptoms lasted about 3 days. I called my doctor about this.
weak; poor balance; was up off; felt "sudden" dizziness; chills; fingers and hands "prickling"; headache; This case was reported by a consumer via call center representative and described the occurrence of dizziness in a 62-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of pain in extremity (received 1st dose in November 2019, for tolerance refer US2020036849).   On 27th February 2020, the patient received the 2nd dose of Shingrix (intramuscular) .5 ml. On 27th February 2020, less than a day after receiving Shingrix, the patient experienced dizziness, chills, tingling of extremity, headache and sleeplessness. On 28th February 2020, the patient experienced weakness and balance difficulty. On 28th February 2020, the outcome of the dizziness, chills, tingling of extremity and headache were recovered/resolved. On an unknown date, the outcome of the weakness and balance difficulty were not recovered/not resolved and the outcome of the sleeplessness was recovered/resolved.   It was unknown if the reporter considered the dizziness, chills, tingling of extremity, headache, weakness, balance difficulty and sleeplessness to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix on left arm. The patient received Shingrix and within 6 or 7 hours, she felt sudden dizziness, chills, finger and hand prickling and headache. She was up off and on most of the night with these symptoms and they had resolved in the morning of 28th February 2020. She felt weak and had poor balance that continues at this time. The reporter consented for follow up. For tolerance after 2nd dose refer case US2020036850.
Reddened area around injection site no pain no itch. Stated that it feels like a bruise. No treatment.
I lost taste for a day (1st dose); a lot of fatigue (1st dose); headache (1st dose); This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (a lot of fatigue (1st dose)), HEADACHE (headache (1st dose)), AGEUSIA (I lost taste for a day (1st dose)) and BODY TEMPERATURE INCREASED (temperature that lasted two days ) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-May-2021, the patient experienced FATIGUE (a lot of fatigue (1st dose)), HEADACHE (headache (1st dose)) and BODY TEMPERATURE INCREASED (temperature that lasted two days ). On an unknown date, the patient experienced AGEUSIA (I lost taste for a day (1st dose)). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. On 10-May-2021, FATIGUE (a lot of fatigue (1st dose)), HEADACHE (headache (1st dose)) and BODY TEMPERATURE INCREASED (temperature that lasted two days ) had resolved. At the time of the report, AGEUSIA (I lost taste for a day (1st dose)) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-May-2021, Body temperature: abnormal (abnormal) temperature that lasted two days, Recovered on 10/May/2021.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication reported.   This case was linked to MOD-2021-220933 (Patient Link).
8AUG95 pt recvd vax & 8AUG early evening devel small bruise, swelling & redness @ needle site;by 10AUG 4" circle noted swollen, red & hot, sma amount blood noted form puncture site;mom took pt to MD; rx site as an infect w/duricef;
Patient vaccinated per procedure.  Did not mention previous vaccination other than the primary series was received.  When documenting vaccination it was noted that the patient had been vaccinated on 2/4/22 with a dose of Pfizer-BioNTech vaccine.  Followed up with client and their caregiver.  No adverse outcomes noted.
One week post vax the pt developed chickenpox. The physician reported that it was not a really bad case.
Information has been received from a registered nurse concerning a 9 year old male with no allergies or medical history who on 26-JUN-1998 was vaccinated SC in the right arm with a first dose of Varivax (lot # 625047/1574E). Concomitant vaccination on the same day included a SC first dose of MMR (lot # 623743/0505H). There was no illness at the time of vaccination. On 18-JAN-2007, the patient's mother stated that the child had one red spot on his face. By 19-JAN-2007, he had about 60 all over his body. They were itchy and slight painful. The patient recovered on an unspecified date. No diagnostic laboratory tests were performed. Additional information is not expected.
I have developed all the indicated possible adverse reactions (e.g. fever, chills, body aches, exhaustion, headache, nausea) but also a DRY COUGH that continues for several days.
Hives and itching on arms, legs and trunk. Took Benadryl and used hydrocortisone topical cream.
I received my first dose of the COVID-19 Moderna vaccine on 12/29 at 12:40p at Medical Center in my left deltoid. I am a registered nurse at the facility. Starting on 12/30 when I woke up, I had a mild headache. The headache is lingering and intermittent. Starting 1/3, I have a swollen and sore lymph node in my left armpit (the same side I received the vaccine). My employer is sending me for a COVID-19 PCR today to rule out any active infection. Tylenol has been taken as needed for the headache.
Pulmonary Embolism, blood clot left lung. Put on Eliqust 10 mgs a day.
Next morning after shingles vaccine  was given to me, I woke with 2 red  blisters on my right side of chest - pain  Felt itchy took 5-6 days to go away -  few weeks later I got another blister on  right side of chest - back & itch - happened a few  more times - went to dermatologist 11-14-20 Every week or so, I break out on a large red  blister that is painful & itchy - never had this  before - started morning after shingles vaccine.  Dermatologist said it was Herpes-Simplex  wanted to know if I was worried or under  stress (which I was not) I am worried that this will keep  happening - I keep breaking out with 1 or 2 of these every few weeks - never had anything like this, ever -  Do not know if the person who  treated me at medical clinic really knew if or what it really is.  Supposed to get the 2nd shot but I am leary and afraid - do not know what to do.
Fever, chills, joint pain, headache, nausea, fatigue, bodyaches
injection site pain; This case was reported by a nurse via call center representative and described the occurrence of injection site pain in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 11th November 2019, the patient received the 1st dose of Shingrix (intramuscular). On 11th November 2019, immediately after receiving Shingrix, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was recovered/resolved.   It was unknown if the reporter considered the injection site pain to be related to Shingrix.  Additional details were provided as follows: The reporting nurse was the concerned patient. The age at vaccination not provided. Injection site pain lasted for 1 to 2 days. For tolerances of 2nd dose of Shingrix, refer case US2020018231. The follow up consent was granted.
Vaccine admin in (L) deltoid on 10/1/13. No complaints made by pt. Pt states her deltoid started hurting immediately and has worsened. Redness, swelling in most of (L) upper arm. Bad pain. Hot to touch. Radiating pain into shoulder and rest of arm. Weakness.
ringing in the ear; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (ringing in the ear) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TINNITUS (ringing in the ear). At the time of the report, TINNITUS (ringing in the ear) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided by reporter. Treatment information was not provided by reporter.
3/15 right after shot arm turned red and hot to touch.  4 days later she turned cherry red on trunk and arm got bulls eye pattern of blisters, edema at shot site, left thigh developed sm area of shingles type lesions on 3/19/08.
Local site reaction on left arm. She was experiencing soreness, redness, swelling and itching at the injection site. The site was warm to the touch but no pt. fever. Pt. going to walkin clinic.
no adverse events; A patient received a dose of PEDV AX on 02/01/2019, on 04/01/2019, on 06/01/2019, and on 09/09/2019; This spontaneous report as received from an administrator refers to a patient of unknown age and gender. No information on patient's pertinent medical history, concomitant medications and drug reactions or allergies was provided.  On 01-FEB-2019, the patient was vaccinated with a first dose of haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) (lot#, expiration date, dose and route of administration were not provided) for prophylaxis. The patient was vaccinated with a second, third and fourth dose of haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) (lot#, expiration date, dose and route of administration were not provided) for prophylaxis, on 01-APR-2019, 01-JUN-2019 and 09-SEP-2019, respectively. No known adverse effects were reported.
The next night after getting the shot started to feel blah all the way into Sunday evening. Has had the sniffles and the injection site was red the day of on Thursday all the way to mid-day Saturday.
Call from school nurse with child having SOB, elevated heart rate, decreased O2 saturation less than 24 hours from vaccines recieved, sent to ER.
charlie horse in arm; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (charlie horse in arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MUSCLE SPASMS (charlie horse in arm). At the time of the report, MUSCLE SPASMS (charlie horse in arm) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medications were reported. No treatment information was reported.   This case was linked to MOD-2021-283130 (Patient Link).
Pt received 10mcg/0.5 ml instead of 20mcg/1cc. No untoward event however patient now requires redosing.
Injection site displaying  red circular mark on skin, even as of today 06/04/2021 Site is pain free, and arm is fully functional.  no pain in arm. no other adverse affects from shot
very sick; flu; arm is still in pain for more than 2 weeks now; chills; so tired; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (very sick), INFLUENZA (flu), PAIN IN EXTREMITY (arm is still in pain for more than 2 weeks now), CHILLS (chills) and FATIGUE (so tired) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016BNA) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, the patient experienced ILLNESS (very sick), INFLUENZA (flu), PAIN IN EXTREMITY (arm is still in pain for more than 2 weeks now), CHILLS (chills) and FATIGUE (so tired). At the time of the report, ILLNESS (very sick), INFLUENZA (flu), PAIN IN EXTREMITY (arm is still in pain for more than 2 weeks now), CHILLS (chills) and FATIGUE (so tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment was taken for the events. Concomitant medications included unspecified vitamins.
This spontaneous report received from a physician via field representative refers to a 60 year old female patient. On 17-DEC-2013 the patient was vaccinated with ZOSTAVAX injection lot # J008434 and expiry date 11-OCT-2014 (reported as unspecified) dose 1 for shingles prevention. Concomitant therapies included potassium (manufacturer unknown), hydrochlorothiazide, MAXZIDE, estrogens, PREMARIN, CELEBREX and NEURONTIN. On 20-DEC-2013, the patient experienced vesicular pox like rash after vaccination. On 27-DEC-2013 the physician had seen the patient who complained that this rash was itchy. The physician treated the patient with VALTREX and a MEDROL patch. After prescribing this, the physician told the patient to come back to the office if this adverse experience did clear up in a week. The patient did not come back to the office, so the reporter (field representative) assumed that the patient had recovered from this adverse experience. The outcome of vesicular pox like rash and rash was itchy was unknown. Additional information has been requested.
Patient stopped by to report significant bruise at injection site. Bruise was approx. 1 1/2-2 inches in diameter. No redness, heat, lump or swelling reported. Asked her to check back in 1 week if not resolved. Did not come back, so hopefully now resolved.
Raised red circle 2 inches in diameter around injection site noticed 10 days after vaccine. Warm to the touch, hard lump, swollen. All around injection site.
large dark bruise, 3 inches in diameter with spidery dark areas travelling down veins, migraine that has lasted since night of vaccination until present.  Intense vomiting due to migraine. Fever, neck pain in back of neck.
This spontaneous report as received from a Registered Nurse refers to unspecified patients of unknown age and gender. Medical history and concurrent conditions were not provided. Since 02-FEB-2015, unspecified patients were vaccinated with a dose of improperly stored PNEUMOVAX 23 (dose, route, lot number and expiry date were not reported). No adverse effects were reported. There was no concomitant medication provided. This is one of several reports received from the same reporter. Additional information has been requested.
5 hours after the shingles vaccine on 1/14/21 I could not form words and it was extremely difficult to speak. The wrong word came out. I felt dizzy and out of it. This lasted for 2-3 hours. The next day it was much better but I still feel that problem a little bit. Secondly, I felt tingling in my head, arms and legs since then, slowly waning.
GIVEN ADULT BIVALENT BOOSTER NEEDED PEDIATRIC BIVALENT BOOSTER
Around 3:00 AM I woke feeling violently ill - dizzy - vertigo. Tried to walk to bathroom but passed out and fell in bedroom. Husband awoke and helped me to bed. Vomiting ensued. Could not sit upright. Lost bodily control. Severe diarrhea. Husband called clinic at 0700. Symptoms started to subside by mid afternoon. Took another day to recover.
Nausea, body aches, headache, exhaustion, pain in left armpit/axillary area started 2 days post injection, pain and tenderness around injection area.
My heart began racing about 3 minutes after receiving the shot. It lasted about 10 minutes. I was slightly light headed for a minute or 2.,I felt fine after about 20 minutes.
sore arm; This case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was captured as adult as per the vaccine indication. After receiving Shingrix, the patient had sore arm. For the tolerance of 2nd dose, refer linked case US2021AMR024485.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR024485:same patient
Sore throat and hoarseness; Sore throat and hoarseness; Vomiting all throughout the night and into the following day; Chest heaviness and described it "as if I was having a heart attack."; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (Chest heaviness and described it "as if I was having a heart attack."), OROPHARYNGEAL PAIN (Sore throat and hoarseness), DYSPHONIA (Sore throat and hoarseness) and VOMITING (Vomiting all throughout the night and into the following day) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Mar-2021, the patient experienced CHEST DISCOMFORT (Chest heaviness and described it "as if I was having a heart attack.") and VOMITING (Vomiting all throughout the night and into the following day). On 23-Mar-2021, the patient experienced OROPHARYNGEAL PAIN (Sore throat and hoarseness) and DYSPHONIA (Sore throat and hoarseness). At the time of the report, CHEST DISCOMFORT (Chest heaviness and described it "as if I was having a heart attack."), OROPHARYNGEAL PAIN (Sore throat and hoarseness) and DYSPHONIA (Sore throat and hoarseness) outcome was unknown and VOMITING (Vomiting all throughout the night and into the following day) had resolved.            Concomitant product used was not provided by the reporter.